Hormone replacement therapy and risk of nonfatal acute myocardial infarction in Italy

Journal of Clinical Epidemiology

Volumn 58, Issue 7, 2005, Pages 747-750

  Tavani, Alessandra ^a   Bertuzzi, Michaela ^a   Gallus, Silvano ^a   Negri, Eva ^a   La Vecchia, Carlo ^a,b  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Acute myocardial infarction; Case control studies; Epidemiology; Hormone replacement therapy; Risk factors

Indexed keywords

ESTROGEN; GESTAGEN;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CASE CONTROL STUDY; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; HORMONE SUBSTITUTION; HOSPITAL; HUMAN; MEDICAL RECORD; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RISK ASSESSMENT; SAMPLE SIZE;

AGE DISTRIBUTION; AGED; CASE-CONTROL STUDIES; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; ITALY; MIDDLE AGED; MYOCARDIAL INFARCTION; ODDS RATIO; RISK FACTORS;

EID: 20444412719     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jclinepi.2004.01.023     Document Type: Article

References (25)

1. E. Barrett-Connor, and C.A. Stuenkel Hormone replacement therapy (HRT)- risks and benefits Int J Epidemiol 30 2001 423 426
2. T.W. Meade, and M.R. Vickers HRT and cardiovascular disease J Epidemiol Biostat 4 1999 165 190
3. F. Grodstein, M.J. Stampfer, J.E. Manson, G.A. Colditz, W.C. Willett, B. Rosner, F.E. Speizer, and C.H. Hennekens Postmenopausal estrogen and progestin use and the risk of cardiovascular disease N Engl J Med 335 1996 453 461
4. L. Mosca, P. Collins, D.M. Herrington, M.E. Mendelsohn, R.C. Pasternak, R.M. Robertson, K. Schenck-Gustafsson, S.C. Smith Jr., K.A. Taubert, and N.K. Wenger Hormone replacement therapy and cardiovascular disease: a statement for healthcare professionals from the American Heart Association Circulation 104 2001 499 503
5. H.D. Nelson, L.L. Humphrey, P. Nygren, S.M. Teutsch, and J.D. Allan Postmenopausal hormone replacement therapy. Scientific review JAMA 288 2002 872 881
6. V. Beral, E. Banks, and G. Reeves Evidence from randomized trials on the long-term effects of hormone replacement therapy Lancet 360 2002 942 944
7. D.C.G. Skegg Hormone therapy and heart disease after the menopause Lancet 358 2001 1196 1197
8. M.E. Mendelsohn, and R.H. Karas Protective effects of estrogen on the cardiovascular system N Engl J Med 340 1999 1801 1811
9. The Writing Group for the PEPI Trial Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial JAMA 273 1995 199 208
10. E. Hemminki, and K. McPerson Impact of postmenopausal hormone therapy on cardiovascular events and cancer: pooled data from clinical trials Br Med J 315 1997 149 153
11. E. Hemminki, and K. McPerson Value of drug-licensing documents in studying the effect of postmenopausal hormone therapy on cardiovascular disease Lancet 355 2000 566 569
12. S. Hulley, D. Grady, T. Bush, C. Furberg, D. Herrington, B. Riggs, E. Vittinghoff, and for the Heart and Estrogen/progestin Replacement Study (HERS) Research Group Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women JAMA 280 1998 605 613
13. D. Grady, D. Herrington, V. Bittner, R. Blumenthal, M. Davidson, M. Hlatky, J. Hsia, S. Hulley, A. Herd, S. Khan, L.K. Newby, D. Waters, E. Vittinghoff, N. Wenger, and for the HERS Research Group Cardiovascular disease outcomes during 6.8 years of hormone therapy. Heart and Estrogen/Progestin Replacement Study follow-up (HERS II) JAMA 288 2002 49 57
14. C.M. Viscoli, L.M. Brass, W.N. Kernan, P.M. Sarrel, S. Suissa, and R.I. Horwitz A clinical trial of estrogen-replacement therapy after ischemic stroke N Engl J Med 345 2001 1243 1249
15. Writing Group for the Women's Health Initiative Investigators Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the Women's Health Initiative randomized controlled trial JAMA 288 2002 321 333
16. M.A. Kahn, A.M. Heagerty, H. Kitchener, R. McNamee, N.M. Cherry, and P. Hannaford Oestrogen and women's heart disease: ESPRIT-UK Q J Med 93 2000 699 700
17. M.R. Vickers, and N. Collins Progress on the WISDOM trial - Women's International Study of long duration oestrogen after the menopause Climacteric 5 Suppl 1 2002 133 134
18. Ischemic Heart Disease Registers Report of the Fifth Working Group 1971 World Health Organization Copenhagen
19. C. La Vecchia, S. Franceschi, A. Decarli, S. Pampallona, and G. Tognoni Risk factors for myocardial infarction in young women Am J Epidemiol 125 1987 832 843
20. E. Negri, C. La Vecchia, M.G. Franzosi, G. Tognoni, and GISSI-EFRIM Attributable risks for nonfatal myocardial infarction in Italy Prev Med 24 1995 603 609
21. A. Tavani, C. Pelucchi, E. Negri, M. Bertuzzi, and C. La Vecchia n-3 polyunsaturated fatty acids, fish and non-fatal acute myocardial infarction Circulation 104 2001 2269 2272
22. N.E. Breslow, and N.E. Day Statistical methods in cancer research. Vol. I. The analysis of case-control studies 1980 IARC Scientific Publications Lyon 32
23. N. Mantel, and W. Haenszel Statistical aspects of the analysis of data from retrospective studies of disease J Natl Cancer Inst 22 1959 719 748
24. F. Parazzini, C. La Vecchia, E. Negri, C. Bianchi, and L. Fedele Determinants of estrogen replacement therapy use in northern Italy Rev Epidemiol Sante Publique 41 1993 53 58
25. F. Levi, F. Lucchini, E. Negri, and C. La Vecchia Trends in mortality from cardiovascular and cerebrovascular diseases in Europe and other areas of the world Heart 88 2002 119 124